![Biomolecules | Free Full-Text | Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation Biomolecules | Free Full-Text | Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation](https://pub.mdpi-res.com/biomolecules/biomolecules-10-01387/article_deploy/html/images/biomolecules-10-01387-g001.png?1601374731)
Biomolecules | Free Full-Text | Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
![Smoldering Multiple Myeloma: What Is the Threshold to Start Treatment? in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 12.5 (2020) Smoldering Multiple Myeloma: What Is the Threshold to Start Treatment? in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 12.5 (2020)](https://jnccn.org/view/journals/jnccn/18/12.5/full-jnccn20-5043f1.jpg)
Smoldering Multiple Myeloma: What Is the Threshold to Start Treatment? in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 12.5 (2020)
![iga kappa mgus icd 10, ICD-10 International statistical of diseases and related problems - ciclomobilidade.org iga kappa mgus icd 10, ICD-10 International statistical of diseases and related problems - ciclomobilidade.org](https://www.mdpi.com/cancers/cancers-12-01554/article_deploy/html/images/cancers-12-01554-g001.png)
iga kappa mgus icd 10, ICD-10 International statistical of diseases and related problems - ciclomobilidade.org
Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis | PLOS ONE
![A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib](https://static.hindawi.com/articles/crionm/volume-2014/962526/figures/962526.fig.002.jpg)
A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib
![Frontiers | Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients Frontiers | Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients](https://www.frontiersin.org/files/Articles/575168/fonc-10-575168-HTML/image_m/fonc-10-575168-g001.jpg)
Frontiers | Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
![JCM | Free Full-Text | Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications JCM | Free Full-Text | Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications](https://pub.mdpi-res.com/jcm/jcm-12-01637/article_deploy/html/images/jcm-12-01637-g001.png?1676879605)